• Recombinant Annexin V: A Reliable Probe for Apoptotic Membra

  2026-05-08

  This study details the high-yield expression and purification of recombinant polyhistidine-tagged annexin V in E. coli for sensitive detection of phosphatidylserine externalization during apoptosis. The work enables reproducible, quantitative apoptosis assays and informs membrane biology research through robust FITC-conjugation and flow cytometry techniques.

• Rifampin: Applied Workflows for Bacterial Resistance Researc

  2026-05-07

  Rifampin, a gold-standard rifamycin antibiotic, enables targeted inhibition of bacterial transcription for advanced resistance mechanism studies and synthetic biology. This guide delivers actionable workflow enhancements, addresses common troubleshooting challenges, and integrates literature-backed insights for optimal experimental outcomes.

• Bismuth Subsalicylate in GI Disorder Research: Protocols & T

  2026-05-07

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is a gold-standard Prostaglandin G/H Synthase 1/2 inhibitor for gastrointestinal disorder research, enabling reproducible inflammation pathway modulation and advanced membrane biology assays. This guide delivers actionable workflow enhancements, troubleshooting strategies, and context-driven protocol parameters to maximize reproducibility in GI and cell viability studies.

• Bifendate (DDB): Optimizing Hepatoprotection and Autophagy I

  2026-05-06

  Bifendate (DDB) stands out as a benchmark hepatoprotection agent, uniquely combining lipid regulation, autophagy inhibition, and CYP3A4 modulation. This guide translates recent mechanistic insights into actionable workflows, troubleshooting, and comparative advantages for both in vitro and in vivo liver research.

• JZL184 and Translational Endocannabinoid Modulation: New Par

  2026-05-06

  This thought-leadership article explores the mechanistic, experimental, and translational landscape of JZL184—a potent monoacylglycerol lipase inhibitor—highlighting actionable strategies for translational neuroscientists. By integrating recent advances in CB1 receptor-mediated signaling and GLT-1 regulation post-traumatic brain injury, we deliver nuanced guidance on optimizing endocannabinoid modulation for neuroprotection, pain, and anxiety research. Unique to this piece is a rigorous comparison against prior workflows, a granular protocol section, and a candid discussion of domain boundaries, setting it apart from conventional product-focused content.

• NSC 87877: Shp2 Inhibitor Workflows for Neuroinflammation Re

  2026-05-05

  NSC 87877 stands out as a selective Shp2 inhibitor, enabling precise dissection of neuroinflammatory and oncogenic signaling pathways. This article bridges advanced mechanistic insight with practical experimental workflows and troubleshooting tips, empowering researchers to unlock the full translational value of NSC 87877.

• Personalized iPSC Platform Guides Therapy for Ultrarare Muta

  2026-05-05

  Sequiera et al. developed a patient-specific iPSC-based drug screening platform for an individual with an ultrarare Leigh-like syndrome. This approach enabled the preclinical assessment of drug safety and efficacy, offering a new paradigm for personalized clinical trial selection in the context of rare genetic diseases.

• Applied Workflows with KPT-330 (Selinexor) for Cancer Resear

  2026-05-04

  KPT-330 (Selinexor) brings selective CRM1 inhibition to the forefront of cancer research, enabling robust apoptosis induction and tumor growth suppression in challenging models. This guide delivers actionable protocols, troubleshooting insights, and advanced use-cases, empowering researchers to maximize the compound’s impact in translational oncology.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Workflow, Delivery, and Opti

  2026-05-04

  Discover how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables precise immune modulation, with advanced delivery and troubleshooting strategies informed by the latest virus-mimicking nanoparticle research. This guide translates bench protocols into actionable steps for immunotherapy and gene expression studies.

• Shionone Activates PINK1-Parkin Mitophagy to Counter Pulmona

  2026-05-03

  This study elucidates how shionone, a terpenoid from Ligularia fischeri, mitigates pulmonary fibrosis by activating mitophagy via the PINK1-Parkin pathway. The findings clarify a novel anti-fibrotic mechanism and highlight mitophagy modulation as a promising therapeutic strategy for interstitial lung diseases.

• Phenothiazines Enhance Macrophage Antibacterial Activity via

  2026-05-02

  The reference study demonstrates that phenothiazines, a class of compounds including dopamine D2 receptor inhibitors, significantly boost the antibacterial capacity of macrophages by inducing both autophagy and reactive oxygen species (ROS) accumulation. These findings provide new mechanistic insight into host-directed therapy strategies, highlighting the translational potential of phenothiazines in combating antibiotic-resistant intracellular bacterial infections.

• Maximizing Assay Sensitivity with EZ Cap™ Firefly Luciferase

  2026-05-01

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables superior bioluminescence reporting for gene regulation and in vivo imaging workflows. Learn how optimized capping, poly(A) tail engineering, and lipid nanoparticle delivery converge to produce unmatched expression and data quality, with actionable troubleshooting insights for high-throughput research.

• 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB): Precisi

  2026-05-01

  Explore the advanced applications of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) as a transcriptional elongation inhibitor. This article uniquely bridges DRB’s mechanistic action with ac4C-mediated RNA regulation, offering novel insights for stem cell and antiviral research.

• S Tag Peptide: Technical Guide for Protein Detection & Purif

  2026-04-30

  S Tag Peptide enables efficient detection, affinity purification, and improved solubility of recombinant proteins by serving as a robust fusion tag. It is ideal for workflows requiring anti-S-Tag antibody detection or protein solubility enhancement, but is not suitable when ethanol solubility or long-term aqueous storage is essential.

• Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Assa

  2026-04-30

  Z-VEID-FMK unlocks the selective inhibition of caspase-6, enabling researchers to dissect complex apoptotic pathways and viral immune evasion. Its robust performance in neuronal and immune cell models makes it an indispensable tool for apoptosis, neurodegeneration, and translational antiviral strategies.

8090 records 15/540 page Previous Next First page 上5页 1112131415 下5页 Last page